What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism

BACKGROUND: The private sector supplies anti-malarial treatment for large proportions of patients in sub-Saharan Africa. Following the large-scale piloting of the Affordable Medicines Facility-malaria (AMFm) from 2010 to 2011, a private sector co-payment mechanism (CPM) provided continuation of priv...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Malar J
Hoofdauteurs: Tougher, Sarah, Hanson, Kara, Goodman, Catherine
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2017
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5405529/
https://ncbi.nlm.nih.gov/pubmed/28441956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-017-1814-z
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items